En español
NIDA

Menu

NIDA Notes Articles

NIDA Notes Category Graphic

Study Endorses Onsite HIV Testing Without Risk Reduction Counseling

April 2013

Patients were more likely to take a rapid HIV test when substance abuse treatment programs offered the test onsite rather than referred for offsite testing. Patients were equally likely to accept and learn their HIV status whether the offer of onsite testing was accompanied by 30 minutes of risk reduction counseling or by 5 minutes of brief information on the testing procedure. Onsite testing accompanied by brief information was cost effective, taking into account the projected lifetime costs of treatment and the gains in health and longevity for detected cases.

NIDA Notes Category Graphic

Gabapentin Tested To Treat Marijuana Dependence

April 2013

Marijuana-dependent outpatients who were treated with the medication gabapentin in a pilot clinical trial reduced their cannabis use more and reported fewer symptoms of drug withdrawal than patients who received a placebo.

NIDA Notes Category Graphic

Q & A: Dr. Redonna Chandler

April 2013

The chief of NIDA's Services Research Branch talks about drug abuse treatment within the criminal justice system, and assesses the challenges facing drug abuse treatment overall in the United States.

NIDA Notes Category Graphic

Thoughts of Suicide May Persist Among Nonmedical Prescription Opiate Users

March 2013

People who use prescription opiates nonmedically are more likely to consider suicide than those who use these medications only appropriately or not at all. A recent NIDA-supported study also disclosed that the risk for suicidal thoughts remains elevated after cessation of use.

NIDA Notes Category Graphic

Adolescent Cigarette, Alcohol Use Declines as Marijuana Use Rises

February 2013

Fewer teens are using cigarettes, alcohol, and most illicit drugs, according to NIDA’s latest Monitoring the Future study. Troubling  trends persist in marijuana use, however, and nonmedical prescription drug use remains a concern.

NIDA Notes Category Graphic

Deadline Approaching: U.S.-Mexico Drug Abuse Prevention Research Fellowship

February 2013

Researchers interested in applying for the NIDA U.S.-Mexico Drug Abuse Prevention Research Fellowship need to submit application materials by April 1, 2013. 

NIDA Notes Category Graphic

Nicotine Makes Mouse Brain More Responsive to Cocaine

February 2013

Nicotine sensitizes the mouse brain to the addictive effects of cocaine, according to recent NIDA-supported research. The results accord with the hypothesis that a person’s initial use of an addictive substance physiologically sensitizes his or her brain to the rewarding and addictive effects of other substances. If the findings carry over to people, then preventing youths from smoking might reduce their vulnerability to cocaine abuse and addiction, and cocaine-dependent individuals might ease their path to recovery by quitting smoking.

NIDA Notes Category Graphic

Staff Stress Affects Patients’ Engagement in Therapy

February 2013

Several factors contribute to treatment professionals’ stress and burnout, including how much influence they feel they have in their organization and their caseload. Surprisingly, a NIDA-supported study found that the link between staff stress and burnout was weaker in programs with higher patient caseloads than those with lower caseloads. In addition, program administrators can help counselors reduce their stress by giving them a voice in organizational policies and procedures.  

NIDA Notes Category Graphic

SAAF‒T Reduces African American Teens’ Substance Use, Conduct Problems

February 2013

Teens who participated in the intervention Strong African American FamiliesTeen at age 16 reported fewer conduct problems and depressive symptoms and less substance abuse at age 17‒18, compared to peers exposed to a control intervention.

NIDA Notes Category Graphic

Seek-Test-Treat-Retain To Stop the Spread of HIV

February 2013

Despite the advances in treatment and prevention, roughly 50,000 new HIV infections still occur annually in the Nation. Research, in large part supported by NIDA, has produced a strategy to address this circumstance and break the epidemiological impasse: seek out HIV-infected individuals, particularly those in “hard-to-reach” groups that have minimal contact with the health care system; offer them HIV testing and treatment; and provide support to help them stay in treatment.

Pages

NIDA Notes

Tags

Drug Topics

Drugs of Abuse

Population Groups

Related Topics